Cargando…
S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812111/ http://dx.doi.org/10.1097/01.HS9.0000821440.09294.d3 |
| _version_ | 1784644578927706112 |
|---|---|
| author | Achebe, M Nduba, V Hassab, H Alkindi, S Brown, R Telfer, P Biemond, B Gordeuk, V Lipato, T Tonda, M Gray, S Howard, J |
| author_facet | Achebe, M Nduba, V Hassab, H Alkindi, S Brown, R Telfer, P Biemond, B Gordeuk, V Lipato, T Tonda, M Gray, S Howard, J |
| author_sort | Achebe, M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8812111 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88121112022-02-18 S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL Achebe, M Nduba, V Hassab, H Alkindi, S Brown, R Telfer, P Biemond, B Gordeuk, V Lipato, T Tonda, M Gray, S Howard, J Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8812111/ http://dx.doi.org/10.1097/01.HS9.0000821440.09294.d3 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Presentations Achebe, M Nduba, V Hassab, H Alkindi, S Brown, R Telfer, P Biemond, B Gordeuk, V Lipato, T Tonda, M Gray, S Howard, J S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL |
| title | S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL |
| title_full | S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL |
| title_fullStr | S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL |
| title_full_unstemmed | S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL |
| title_short | S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL |
| title_sort | s118: long-term safety and efficacy of voxelotor for patients with sickle cell disease: results from an open-label extension of the phase 3 hope trial |
| topic | Oral Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812111/ http://dx.doi.org/10.1097/01.HS9.0000821440.09294.d3 |
| work_keys_str_mv | AT achebem s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT ndubav s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT hassabh s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT alkindis s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT brownr s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT telferp s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT biemondb s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT gordeukv s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT lipatot s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT tondam s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT grays s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial AT howardj s118longtermsafetyandefficacyofvoxelotorforpatientswithsicklecelldiseaseresultsfromanopenlabelextensionofthephase3hopetrial |